Effect of change of body mass index (BMI) during therapy on the efficacy of endocrine therapy in premenopausal patients with breast cancer: An analysis of the ABCSG-12 trial.Georg Pfeiler, Michael Gnant, CF Singer et al.|Journal of Clinical Oncology|2011Cited by 4
Impact of body mass index (BMI) on the efficacy of zoledronic acid in premenopausal patients with hormone receptor positive breast cancer: An analysis of the ABCSG-12 trial.Georg Pfeiler, Michael Gnant, Robert Königsberg et al.|Journal of Clinical Oncology|2012Cited by 2